1. Home
  2. ECL vs BSX Comparison

ECL vs BSX Comparison

Compare ECL & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ecolab Inc.

ECL

Ecolab Inc.

HOLD

Current Price

$273.92

Market Cap

77.5B

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$68.89

Market Cap

137.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECL
BSX
Founded
1923
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.5B
137.8B
IPO Year
2007
2010

Fundamental Metrics

Financial Performance
Metric
ECL
BSX
Price
$273.92
$68.89
Analyst Decision
Buy
Strong Buy
Analyst Count
16
20
Target Price
$317.40
$108.75
AVG Volume (30 Days)
1.2M
11.3M
Earning Date
05-18-2026
05-06-2026
Dividend Yield
1.06%
N/A
EPS Growth
N/A
55.20
EPS
7.28
1.94
Revenue
$16,081,200,000.00
$9,076,000,000.00
Revenue This Year
$8.56
$12.04
Revenue Next Year
$4.84
$10.48
P/E Ratio
$37.89
$35.33
Revenue Growth
2.16
12.49
52 Week Low
$229.39
$67.56
52 Week High
$309.27
$109.50

Technical Indicators

Market Signals
Indicator
ECL
BSX
Relative Strength Index (RSI) 28.04 30.45
Support Level $261.28 N/A
Resistance Level $279.91 $76.77
Average True Range (ATR) 5.64 1.87
MACD -3.97 0.06
Stochastic Oscillator 0.66 17.55

Price Performance

Historical Comparison
ECL
BSX

About ECL Ecolab Inc.

Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: